Full-Time

Care Transition Coordinator

Deadline 1/15/27
BrightSpring Health Services

BrightSpring Health Services

10,001+ employees

Home-based and community health services, pharmacy

No salary listed

Lumberton, NC, USA

In Person

Category
Operations & Logistics (1)
Requirements
  • Minimum of one (1) year of experience in home health or hospital-based case management.
  • Current and active licensure in the state of practice as a Registered Nurse (RN), Licensed Practical Nurse (LPN), Social Worker (SW), or Physical Therapist (PT) is required.
  • Must possess a valid driver’s license, reliable transportation, and current auto insurance.
  • Demonstrated understanding of home health eligibility criteria and Medicare/insurance coverage guidelines is required.
Responsibilities
  • Achieve monthly personal production goals and Medicare-certified (MC) admission targets for assigned locations. Manage sales and marketing expenses to ensure financial stewardship and return on investment.
  • Implement weekly, monthly, and quarterly strategies to increase market share within assigned facilities.
  • Evaluate patients and physician orders for home care eligibility in accordance with Right of Choice guidelines.
  • Conduct face-to-face patient transitions to provide agency education and identify the primary care physician responsible for the plan of care.
  • Present identified patient needs to the Executive Director to obtain branch approval and acceptance. Complete Care Transition Coordinator (CTC) encounter documentation in Home Care Home Base.
  • Upon patient acceptance, coordinate transfer orders and ancillary services (e.g., DME, infusion). Educate patients on home care or hospice orders and related services received from the referral source.
  • Ensure all patient needs identified by the referral source are documented and addressed by the agency upon acceptance.
  • Collaborate with the Executive Director and Clinical Director to promote growth by aligning team efforts with the needs and expectations of referral sources and patients.
  • Perform sales administration duties including BOA expense entry, adherence to BOA policies and procedures, payroll timesheet submission, participation in weekly 3LS meetings, submission of PTO requests, and attendance at required sales calls and company-provided in-services. Maintain timely communication via phone and email.
  • Educate patients on the importance of post-discharge physician appointments, obtaining necessary prescriptions prior to discharge, and understanding medication regimens, pharmacy use, and delivery methods.
  • Act as liaison between the agency and healthcare providers for newly referred patients and existing patients transferred to hospitals from home health services.
  • Notify discharge planning of active patients transferred from home health to a facility. Coordinate resumption of care with patients prior to discharge when applicable orders are obtained.
  • Provide follow-up feedback to the case management team on readmission status and non-admit decisions based on agency-provided information.
  • Maintain patient confidentiality in accordance with applicable laws and agency policies.
  • Demonstrate knowledge of agency services, competitive advantages, specialty programs, and Medicare guidelines. Educate medical professionals using appropriate tools and literature.
Desired Qualifications
  • One (1) to three (3) years of experience in medical marketing or healthcare business development.
  • Respiratory Therapist (RT) certification and/or completion of a technical clinical program demonstrating strong clinical knowledge is preferred.
BrightSpring Health Services

BrightSpring Health Services

View

BrightSpring Health Services provides home and community-based health care through two main operations: Pharmacy and Provider. In Pharmacy, it offers services for patients with complex and chronic conditions, including specialty, infusion, and community pharmacy solutions. In Provider, it delivers home health, behavioral health, hospice care, and services for intellectual and developmental disabilities. The company uses an integrated care model that connects pharmacy services with in-home care across its network to support patients, families, and managed care organizations. Revenue comes from reimbursed services paid by Medicare, Medicaid, and private insurers. Its goal is to coordinate ongoing, in-home and community-based care across a continuum—from pharmacy support to direct care—ensuring coordinated, patient-centered services for individuals with complex or chronic needs.

Company Size

10,001+

Company Stage

Post IPO Equity

Headquarters

Louisville, Kentucky

Founded

1974

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 2026 revenue hit $3.61B, up 26%, raising full-year guidance to $14.98B.
  • Amedisys and LHC acquisitions add 107 locations, contributing $30M EBITDA in 2026.
  • Sevita sale yields $811M cash for debt reduction and $2B M&A through 2028.

What critics are saying

  • Money Message ransomware stole 2M records including SSNs in March 2023 breach.
  • DOJ fined ResCare in October 2019 for fake Medicaid revaluations from 2009-2014.
  • Pomerantz investigates securities fraud by BrightSpring officers as of 2026.

What makes BrightSpring Health Services unique

  • BrightSpring integrates specialty pharmacy with home health for complex chronic care patients.
  • PharMerica dispenses 40 million prescriptions annually to 4 million patients.
  • Provider services target intellectual disabilities via home-based behavioral health.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at BrightSpring Health Services who can refer or advise you

Benefits

Flexible Work Hours

Company News

Yahoo Finance
Apr 10th, 2026
BrightSpring Health shares jump 5.2% on 15-20% EBITDA growth targets and AI efficiency plans

BrightSpring Health Services announced the resignation of Robert Barnes as President of ResCare Community Living on 30 March 2026, stating it was not due to any disagreement over operations or policies. The company's shares rose 5.2% following upbeat analyst reports from its investor day. Management unveiled ambitious long-term organic EBITDA growth targets of 15% to 20% annually through 2028, alongside AI-driven efficiency plans for its home and community-based care platform. The narrative projects $16.8 billion in revenue and $361.8 million in earnings by 2028, requiring 10.1% yearly revenue growth. Investors remain focused on whether BrightSpring can balance acquisition-driven expansion and technology investment whilst managing its substantial debt load and regulatory exposure.

Yahoo Finance
Mar 30th, 2026
BrightSpring Health Services stock surges 43% in 6 months, but low ROIC raises concerns

BrightSpring Health Services has seen its stock price surge 43.1% over the past six months to $42.32 per share, driven by strong quarterly results. The healthcare services company, founded in 1974, offers home health care, hospice, neuro-rehabilitation and pharmacy services. BrightSpring's revenue grew at an 18.3% compound annual growth rate over the past five years, outpacing the healthcare sector average. Analysts forecast 15% revenue growth over the next 12 months, though this represents a deceleration from its recent 20.9% annual rate. However, the company's five-year average return on invested capital of 4.9% falls below the typical cost of capital for healthcare firms, suggesting historically mediocre capital efficiency. The stock currently trades at 27.7× forward price-to-earnings ratio.

Yahoo Finance
Mar 25th, 2026
BrightSpring trades at 24.5x forward P/E despite $600M revenue headwinds

BrightSpring Health Services has raised questions about its valuation after trading at 24.5 times forward earnings following strong 2025 performance. The company reported fourth-quarter revenue of $3.55 billion, up 29.3% year-over-year, with adjusted EBITDA rising 40.7% to $184 million. For 2026, management guided revenue between $14.45 billion and $15 billion, representing 11.9% to 16.2% growth, whilst adjusted EBITDA is expected to grow faster at 23% to 28%, indicating margin expansion. However, the company faces approximately $600 million in revenue headwinds from Inflation Reduction Act impacts and brand-to-generic conversions. The valuation hinges on whether BrightSpring can deliver sequential profitability improvements throughout the year despite policy and product-mix pressures affecting headline revenue growth.

Yahoo Finance
Mar 24th, 2026
BrightSpring tops Q4 senior health earnings as Chemed's $639M revenue disappoints

BrightSpring Health Services led senior health stocks in Q4 earnings, reporting revenues of $3.55 billion, up 16.3% year on year and beating analyst expectations by 5%. The company delivered strong full-year EBITDA guidance. In contrast, Chemed posted the weakest performance, with revenues of $639.3 million falling 3% short of expectations. The company missed both revenue and full-year EPS guidance estimates, sending shares down 19.2% to $377.07. The seven senior health, home health and hospice stocks tracked reported slower Q4 results overall, with revenues beating consensus estimates by just 1.1%. Share prices have declined an average of 9.6% since earnings releases. The sector faces headwinds from labour shortages and wage inflation whilst benefiting from an ageing population and growing preference for in-home care.

Yahoo Finance
Mar 19th, 2026
BrightSpring projects sub-2x leverage in 2026, unveils $2B M&A firepower and integrated care strategy

BrightSpring Health Services outlined its growth strategy at an investor day, highlighting a shift towards core home-and-community clinical services. The company's planned community-living divestiture will close soon to boost cash flow and support integrated care initiatives. BrightSpring reported significant deleveraging from approximately 4.5x post-IPO to 2.99x (2.6x pro forma), with leverage expected to fall below 2x in 2026. The company reiterated 2026 guidance of $14.45–$15.0 billion revenue and $760–$790 million adjusted EBITDA, whilst targeting 15–20% organic adjusted EBITDA compound annual growth for 2026–2028. The healthcare services provider has at least $2 billion available for acquisitions through 2028. Its operations include dispensing over 40 million prescriptions annually through PharMerica, serving more than 4 million patients, with recent branch integrations expected to add approximately $30 million of EBITDA.